Provided by Tiger Trade Technology Pte. Ltd.

Edgewise Therapeutics, Inc.

31.45
+0.84002.74%
Post-market: 31.500.0500+0.16%19:32 EDT
Volume:682.13K
Turnover:21.38M
Market Cap:3.37B
PE:-19.29
High:31.69
Open:30.81
Low:30.51
Close:30.61
52wk High:35.00
52wk Low:12.15
Shares:107.27M
Float Shares:60.85M
Volume Ratio:0.46
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6302
EPS(LYR):-1.6302
ROE:-34.19%
ROA:-23.02%
PB:6.46
PE(LYR):-19.29

Loading ...

BRIEF-Edgewise Therapeutics Reports Inducement Grants As Permitted By The Nasdaq Listing Rules

Reuters
·
Yesterday

Edgewise Therapeutics grants inducement stock options for 266,000 shares at $30.96 each

Reuters
·
Yesterday

Edgewise Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

THOMSON REUTERS
·
Yesterday

Edgewise Therapeutics (EWTX) Valuation Check After Strong Multi Year Shareholder Returns

Simply Wall St.
·
Apr 25

Edgewise Therapeutics Faces Near-Term Upside From Cytokinetics' Upcoming Readout, RBC Says

MT Newswires Live
·
Apr 25

Why Edgewise Therapeutics (EWTX) Is Up 8.1% After New Sevasemten BMD Data And Analyst Interest

Simply Wall St.
·
Apr 06

Edgewise Therapeutics (EWTX) Valuation After Positive Becker Muscular Dystrophy Extension Data

Simply Wall St.
·
Apr 04

Edgewise CMO Joanne Donovan disposes of 28,662 shares for $0.93 million

Reuters
·
Apr 03

Edgewise Therapeutics grants inducement stock options for 72,000 shares to new hires

Reuters
·
Apr 01

Edgewise Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

THOMSON REUTERS
·
Apr 01

Edgewise CMO Joanne Donovan disposes of $685k common shares

Reuters
·
Apr 01

Top Executive’s Move at Edgewise Therapeutics Sparks Investor Buzz

TIPRANKS
·
Mar 31

Edgewise CMO Joanne Donovan disposes of $1.3 million common shares

Reuters
·
Mar 31

Edgewise Therapeutics Is Maintained at Overweight by JP Morgan

Dow Jones
·
Mar 17

Edgewise Therapeutics Price Target Maintained With a $32.00/Share by Wedbush

Dow Jones
·
Mar 17

U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson

Reuters
·
Mar 17

Edgewise Therapeutics Inc : JP Morgan Raises Target Price to $45 From $34

THOMSON REUTERS
·
Mar 17

Analysts’ Top Healthcare Picks: Edgewise Therapeutics (EWTX), Sarepta Therapeutics (SRPT)

TIPRANKS
·
Mar 16

Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (DFTX), Integer Holdings (ITGR) and Edgewise Therapeutics (EWTX)

TIPRANKS
·
Mar 11

Edgewise Therapeutics Says Sevasemten Shows Long-Term Functional Stability in Becker Muscular Dystrophy

MT Newswires Live
·
Mar 10